In big boost to India`s COVID-19 battle, Hetero`s Tocilizumab biosimilar gets DCGI`s nod

The company informed this will enable medical practitioners to use the drug for the treatment of COVID-19 in hospitalised adults who are receiving systemic corticosteroids and require supplemental oxygen.

from Zee News :India National https://ift.tt/3zPqgTy

• Tweet
• Share
• Share
• Share
• Share